Associated Retina Consultants
				
				Phoenix, Arizona 85020
We've found
        6 trials
        at this facility
      	
	Neovascular Age-Related Macular Degeneration Clinical Trial
	
Updated: 12/31/1969
  
  
  Extension Study for the Port Delivery System With Ranibizumab (Portal)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neovascular Age-Related Macular Degeneration Clinical Trial
	
Updated: 12/31/1969
  
  
  A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Wet Macular Degeneration Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Macular Degeneration Clinical Trial
	
Updated: 1/7/2016
  
  
  Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 1/7/2016
Click here to add this to my saved trials
	    
	 
  	
	Diabetic Macular Edema Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Geographic Atrophy Clinical Trial
	
Updated: 12/31/1969
  
  
  Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	